Jazz Pharmaceuticals plc
JAZZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,615 | $7,785 | $9,963 | $7,605 |
| - Cash | $2,413 | $1,506 | $881 | $591 |
| + Debt | $6,162 | $5,792 | $5,812 | $6,153 |
| Enterprise Value | $11,365 | $12,070 | $14,894 | $13,166 |
| Revenue | $4,069 | $3,834 | $3,659 | $3,094 |
| % Growth | 6.1% | 4.8% | 18.3% | – |
| Gross Profit | $3,623 | $3,399 | $3,119 | $2,653 |
| % Margin | 89% | 88.6% | 85.2% | 85.8% |
| EBITDA | $1,522 | $1,449 | $1,469 | $1,028 |
| % Margin | 37.4% | 37.8% | 40.1% | 33.2% |
| Net Income | $560 | $415 | -$224 | -$329 |
| % Margin | 13.8% | 10.8% | -6.1% | -10.6% |
| EPS Diluted | 8.65 | 6.1 | -3.58 | -5.51 |
| % Growth | 41.8% | 270.4% | 35% | – |
| Operating Cash Flow | $1,396 | $1,092 | $1,272 | $779 |
| Capital Expenditures | -$48 | -$24 | -$498 | -$46 |
| Free Cash Flow | $1,348 | $1,068 | $774 | $733 |